Physician profile
Mark David Lins
NPI 1194816132
$828.58
in general payments reported to CMS, 2019-2025
17 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $96.80 · 2021: $59.47 · 2022: $178 · 2023: $138 · 2024: $98.24 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $174.40 | 2019-2023 | |
| Cranial Technologies, INC | $93.84 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $88.59 | 2019-2025 | Vaxelis, Gardasil 9, Vaqta |
| Ironshore Pharmaceuticals INC. | $82.82 | 2020-2024 | Jornay Pm |
| Tris Pharma INC | $79.77 | 2019-2022 | |
| Corium, LLC | $68.04 | 2022-2024 | Azstarys |
| Sanofi Pasteur INC. | $38.40 | 2025 | |
| Seqirus USA INC | $33.68 | 2022-2025 | Flucelvax |
| Astrazeneca Pharmaceuticals Lp | $29.68 | 2024 | Flumist Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $25.47 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $21.48 | 2025 | Neffy |
| Phadia US INC. | $17.92 | 2022 | |
| Neos Therapeutics, Lp | $16.91 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.65 | 2025 | Jornay Pm |
| Kaleo, INC. | $15.55 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $14.51 | 2022 | |
| Adlon Therapeutics L.P. | $11.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.